European manufacturing facilities, this may also impact our customers and their demand for our products. We continue to monitor these situations and their impact on our business.
On March 11, 2020, the WHO declared the outbreak of COVID-19 to be a global pandemic and recommended containment and mitigation measures. Many of the limitations and mandates on operations have been lifted, however, the COVID-19 pandemic and its related effects continue to have an adverse effect on many sectors of the economy and we may be further impacted.
Our period-over-period results by reportable segment follow.
Changes Related to Operating Income by Reportable Segment:
Net Sales. Net sales for Unallocated Corporate & Other represents the elimination of inter-segment sales for the three months ended January 31, 2023 and 2022.
Cost of Sales. Cost of sales for Unallocated Corporate & Other consists of the elimination of inter-segment sales, profit in inventory, and other costs.
Changes related to Non-Operating Items:
Historically, our principal sources of funds have been cash on hand, cash flow from operations, and borrowings under our credit facilities.
Cash provided by (used for) operating activities $ 3,135 $ (21,651)
Critical Accounting Policies and Estimates
© Edgar Online, source Glimpses